<DOC>
	<DOCNO>NCT02926976</DOCNO>
	<brief_summary>The Optimal Treatment Treatment-resistant Schizophrenia</brief_summary>
	<brief_title>The Optimal Treatment Treatment-resistant Schizophrenia</brief_title>
	<detailed_description>To explore curative effect safety Risperidone，aripiprazole，sodium valproate，modified electroconvulsive therapy ( MECT ) , Magnetic seizure therapy ( MST ) Clozapine treatment treatment-resistant schizophrenia， provide basis clinical medication .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>The diagnosis schizophrenia accord DSMV 18～60 year old 2 prior fail treatment trial 2 different antipsychotic dos least 600 mg/day chlorpromazine equivalent , least 6 week duration ; Signed informed consent patient diagnose accord DSMV substance abuse , development delay suffer serious physical disease accept treatment MST contraindication : intracranial metal substance , heart pacemaker cochlear implant , intracranial pressure allergic risperidone , aripiprazole , sodium valproate Participated clinical subject within 30 day Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>